Textbook of Uncommon Cancer, Fifth Edition
Wiley Blackwell | English | May 15, 2017 | ISBN-10: 1119196205 | 1296 pages | PDF | 51.34 mb
by Derek Raghavan (Editor), Manmeet Ahluwalia (Editor), Charles D. Blanke (Editor), Jubilee Brown (Editor), Edward S. Kim (Editor), Gregory H. Reaman (Editor), Mikkael A. Sekeres (Editor)
The fifth edition of the only comprehensive text dealing exclusively with rare or infrequently encountered malignancies in adults and children is an essential resource for any clinical oncologist.
Encompasses all the information needed to diagnose and manage uncommon cancers, an area where advice and guidance is typically scarce
Fully revised with new material and an evidence-based, teach-by-example approach
Provides insight on real-world decision making in the clinical setting
Edited and authored by a highly experienced and senior team of medical oncologists, radiation oncologists, and other specialists, giving a balanced and complete overview
Extensively illustrated in full color throughout, including heat maps to show gene expression
About the Author
Derek Raghavan MD, PhD FACP FRACP FASCO
President of the Levine Cancer Institute and Professor of Medicine, Carolinas HealthCare System, Charlotte, NC, USA
Manmeet S. Ahluwalia MD, FACP
Director, Brain Metastasis Research Program and Dean and Diane Miller Family Endowed Chair in Neuro-Oncology at the Cleveland Clinic Taussig Cancer Institute and Neurologic Institute, Cleveland, OH, USA
Charles D. Blanke MD, FACP FASCO
Professor of Medicine, Knight Cancer Institute and Oregon Health and Sciences University and Chair, SWOG, Portland, Oregon, USA
Jubilee Brown MD
Associate Director of Gynecologic Oncology, Levine Cancer Institute of the Carolinas HealthCare System, Charlotte, NC USA
Edward S. Kim MD, FACP
Chair of Solid Tumor Oncology and Investigational Therapeutics and the Donald S. Kim Distinguished Chair for Cancer Research at the Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA
Gregory H. Reaman MD
Associate Director, Office of Hematology and Oncology Products, CDER, U.S. FDA and Founding Chair of the Children’s Oncology Group, Professor of Pediatrics, George Washington University School of Medicine and Health Sciences and Children’s National Health System, Washington DC, DC, USA
Mikkael A. Sekeres MD, MS
Director of the Leukemia Program at the Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA
Download File Size:47.23 MB
|
